Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)
暂无分享，去创建一个
X. Mariette | J. Gottenberg | V. Devauchelle-Pensec | R. Jaussaud | P. Jeandel | Z. Amoura | A. Korganow | E. Hachulla | I. Melki | P. Quartier | R. Seror | S. Ottaviani | D. Cornec | P. Cacoub | A. Mékinian | Y. Allenbach | M. Truchetet | E. Chatelus | C. Larroche | B. Bienvenu | L. Bouillet | B. Rouvière | A. Guffroy | R. Felten | C. Richez | M. Gatfossé | C. Sordet | J. Henry | B. Terrier | E. Gaigneux | A. Leurs | J. Sibilia | J. Kleinmann | H. Nielly | M. Jouvray | M. Michaud | A. Dellal | V. André | A. Saunier | M. Desmurs | A. Meyer | Antoine Poulet | G. Baulier | Guillaume Vial | A. Chaudier | Mathieu Ete | Samira Litim-Ahmed-Yahia